Dexcom launches FDA-approved over-the-counter continuous glucose monitor Stelo for adults with type 2 diabetes.
Dexcom has launched Stelo, the first FDA-approved over-the-counter continuous glucose monitor, available without a prescription. Targeted at adults 18 and older with type 2 diabetes who don't use insulin, Stelo costs $99 per month for a two-pack and can be worn for up to 15 days. It connects to a smartphone app to provide glucose readings every 15 minutes, increasing access for those without insurance coverage.
September 03, 2024
49 Articles